351 related articles for article (PubMed ID: 37628933)
1. Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis.
Giuli L; Pallozzi M; Venturini G; Gasbarrini A; Ponziani FR; Santopaolo F
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628933
[TBL] [Abstract][Full Text] [Related]
2. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension.
Wanless IR; Wong F; Blendis LM; Greig P; Heathcote EJ; Levy G
Hepatology; 1995 May; 21(5):1238-47. PubMed ID: 7737629
[TBL] [Abstract][Full Text] [Related]
3. Management of hepatic vascular diseases.
Plessier A; Rautou PE; Valla DC
J Hepatol; 2012; 56 Suppl 1():S25-38. PubMed ID: 22300463
[TBL] [Abstract][Full Text] [Related]
4. Porto-sinusoidal vascular disorder.
De Gottardi A; Sempoux C; Berzigotti A
J Hepatol; 2022 Oct; 77(4):1124-1135. PubMed ID: 35690264
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic challenges in non-cirrhotic portal hypertension - porto sinusoidal vascular disease.
Nicoară-Farcău O; Rusu I; Stefănescu H; Tanțău M; Badea RI; Procopeț B
World J Gastroenterol; 2020 Jun; 26(22):3000-3011. PubMed ID: 32587444
[TBL] [Abstract][Full Text] [Related]
6. The ischemic liver cirrhosis theory and its clinical implications.
Mancuso A
Med Hypotheses; 2016 Sep; 94():4-6. PubMed ID: 27515188
[TBL] [Abstract][Full Text] [Related]
7. Porto-sinusoidal vascular disease: proposal and description of a novel entity.
De Gottardi A; Rautou PE; Schouten J; Rubbia-Brandt L; Leebeek F; Trebicka J; Murad SD; Vilgrain V; Hernandez-Gea V; Nery F; Plessier A; Berzigotti A; Bioulac-Sage P; Primignani M; Semela D; Elkrief L; Bedossa P; Valla D; Garcia-Pagan JC;
Lancet Gastroenterol Hepatol; 2019 May; 4(5):399-411. PubMed ID: 30957754
[TBL] [Abstract][Full Text] [Related]
8. Impact of vascular liver disease on the menstrual cycle and metabolic status in premenopausal women.
Stempak-Droissart T; Rousset-Jablonski C; Spritzer PM; Lalhou N; Larger E; Pichard C; Plessier A; Gompel A
Clin Res Hepatol Gastroenterol; 2022 Jan; 46(1):101756. PubMed ID: 34303004
[TBL] [Abstract][Full Text] [Related]
9. Management of splanchnic vein thrombosis.
Elkrief L; Payancé A; Plessier A; d'Alteroche L; Ronot M; Paradis V; Valla D; Rautou PE
JHEP Rep; 2023 Apr; 5(4):100667. PubMed ID: 36941824
[TBL] [Abstract][Full Text] [Related]
10. Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis.
Hernández-Gea V; De Gottardi A; Leebeek FWG; Rautou PE; Salem R; Garcia-Pagan JC
J Hepatol; 2019 Jul; 71(1):175-199. PubMed ID: 30822449
[TBL] [Abstract][Full Text] [Related]
11. Portal vein thrombosis, hepatic decompensation, and survival in patients with porto-sinusoidal vascular disease and portal hypertension.
Zhang X; Durham KM; Garza AA; Murali AR
J Gastroenterol; 2023 Mar; 58(3):268-276. PubMed ID: 36692825
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology and a Rational Basis of Therapy.
Gracia-Sancho J; Maeso-Díaz R; Bosch J
Dig Dis; 2015; 33(4):508-14. PubMed ID: 26159267
[TBL] [Abstract][Full Text] [Related]
13. The genetics of portal hypertension: Recent developments and the road ahead.
Shalaby S; Ronzoni L; Hernandez-Gea V; Valenti L
Liver Int; 2023 Dec; 43(12):2592-2603. PubMed ID: 37718732
[TBL] [Abstract][Full Text] [Related]
14. Causes and Management of Non-cirrhotic Portal Hypertension.
Gioia S; Nardelli S; Ridola L; Riggio O
Curr Gastroenterol Rep; 2020 Sep; 22(12):56. PubMed ID: 32940785
[TBL] [Abstract][Full Text] [Related]
15. Portal vein thrombosis and budd-Chiari syndrome.
Bittencourt PL; Couto CA; Ribeiro DD
Clin Liver Dis; 2009 Feb; 13(1):127-144. PubMed ID: 19150317
[TBL] [Abstract][Full Text] [Related]
16. Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver.
Martín-Llahí M; Albillos A; Bañares R; Berzigotti A; García-Criado MÁ; Genescà J; Hernández-Gea V; Llop-Herrera E; Masnou-Ridaura H; Mateo J; Navascués CA; Puente Á; Romero-Gutiérrez M; Simón-Talero M; Téllez L; Turon F; Villanueva C; Zarrabeitia R; García-Pagán JC
Gastroenterol Hepatol; 2017 Oct; 40(8):538-580. PubMed ID: 28610817
[TBL] [Abstract][Full Text] [Related]
17. Budd-Chiari syndrome: a common complication of Behçet's disease.
Bayraktar Y; Balkanci F; Bayraktar M; Calguneri M
Am J Gastroenterol; 1997 May; 92(5):858-62. PubMed ID: 9149201
[TBL] [Abstract][Full Text] [Related]
18. Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder.
Lampichler K; Semmler G; Wöran K; Simbrunner B; Jachs M; Hartl L; Bauer DJM; Balcar L; Burghart L; Trauner M; Tamandl D; Ba-Ssalamah A; Mandorfer M; Reiberger T; Scheiner B; Scharitzer M
Eur Radiol; 2023 Feb; 33(2):1422-1432. PubMed ID: 36166087
[TBL] [Abstract][Full Text] [Related]
19. Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats.
Coch L; Mejias M; Berzigotti A; Garcia-Pras E; Gallego J; Bosch J; Mendez R; Fernandez M
Hepatology; 2014 Aug; 60(2):633-47. PubMed ID: 24390792
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonography in Liver Vascular Disease.
De Gottardi A; Berzigotti A; Buscarini E; García Criado A
Ultraschall Med; 2018 Aug; 39(4):382-405. PubMed ID: 30071557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
